Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5300
-0.0100 (-1.85%)
Sep 17, 2026, 3:59 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 186.79 million as of September 17, 2026. Its market cap has decreased by -20.97% in one year.
Market Cap
186.79M
Enterprise Value
169.50M
Revenue
86.47M
Ranking
n/a
PE Ratio
50.28
Stock Price
0.53
ChartMarket Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 186.79M, a decrease of -53.89%. That is a compound annual growth rate of -11.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 186.79M | -26.84% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imricor Medical Systems | 663.36M |
| PolyNovo | 663.21M |
| EBR Systems | 219.82M |
| EMVision Medical Devices | 156.63M |
| Saluda Medical | 105.85M |
| Lumos Diagnostics Holdings | 94.48M |
| SomnoMed | 70.33M |
| Cyclopharm | 67.90M |